Jabra Enhance Select 700 vs Otofonix Encore

The Jabra Enhance Select 700 is a premium-priced OTC hearing aid available at $1,795, earning a B grade with a SoundScore of 3.8/5 in our lab testing. This behind-the-ear device ranks #26 of 65 OTC hearing aids tested, placing it in the top 38% of the category. In our testing, the Enhance Select 700 showed notable strengths in comfort-related metrics. Own-voice comfort scored a solid 3.7/5, measuring 1.19 points above the category average—a meaningful advantage for wearers sensitive to the sound of their own voice. Feedback handling was excellent at 5.0/5, well above the 4.54 category average, indicating reliable stability during typical wear. Speech performance presented a mixed picture. Speech in quiet scored a solid 3.1/5, sitting 0.27 points above average. However, speech in noise was a weakness at 1.0/5, falling 0.48 points below the category average—an important consideration if challenging listening environments are a priority. Music streaming scored 2.5/5, which is above the category average by 0.58 points but only mixed in absolute terms. At this price point, several alternatives delivered stronger overall performance in our testing, including the Lucid Tala (4.61/5) and Audicus Omni 2 (4.59/5). The Jabra Enhance Select 300 and Lucid Engage also achieved higher scores at lower prices. The Enhance Select 700 may suit those prioritizing own-voice comfort and feedback stability over speech-in-noise performance, but shoppers should weigh these trade-offs carefully given the premium pricing.

The Otofonix Encore is a budget-priced prescription hearing aid available for $295, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear device ranks #37 of 39 in the Prescription Hearing Aid category, placing it in the bottom tier of its class. In our standardized testing, the Encore demonstrates one clear strength: excellent feedback handling at 4.7/5, which means users are unlikely to experience whistling or squealing during normal use. However, the device shows significant limitations in other areas. Speech intelligibility scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.40 and 1.11 points below category averages respectively. Music streaming performance scored 0.0/5, indicating this device is not suitable for those who want to stream audio content. The Encore uses disposable batteries and comes in a traditional behind-the-ear style. Notably, our tuned fit testing showed a slight decrease in overall performance compared to the initial fit, with the normalized score dropping from 2.8/5 to 2.4/5. Own-voice comfort also declined substantially when moving to a more occluding coupling. At this price point, consumers may want to consider alternatives. The RxEars Rxi offers substantially better performance at a similar budget price point with a score of 4.07/5. The Otofonix Encore may appeal to buyers seeking a very low-cost entry into prescription hearing aids who prioritize feedback stability, but those needing reliable speech clarity or streaming capabilities should explore other options.